62
TITLE: The Timing of Safety Regulatory Decisions Compared with Cumulative Meta-Analysis' Risk Estimates  Full Text
AUTHORS: Carlos Alves; Ana F Macedo; Francisco Batel Marques;
PUBLISHED: 2014, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 23
INDEXED IN: WOS
63
TITLE: Safety Profile of Ophthalmic Biologics: Review of Safety Data  Full Text
AUTHORS: Ana Penedones; Carlos Alves; Francisco Batel Marques;
PUBLISHED: 2014, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 23
INDEXED IN: WOS
64
TITLE: Safety Monitoring of Ophthalmic Biologics: A Systematic Review of Pre- and Postmarketing Safety Data  Full Text
AUTHORS: Penedones, A; Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2014, SOURCE: JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, VOLUME: 30, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
65
TITLE: Safety Monitoring of Ophthalmic Biologics: A Systematic Review of Pre- and Post-Marketing Safety Data  Full Text
AUTHORS: Penedones, A; Mendes, D; Alves, C; Batel Marques, F;
PUBLISHED: 2014, SOURCE: 14th ISoP Annual Meeting on New Ideas in Ancient Cultures - Advancing Pharmacovigilance in Asia in DRUG SAFETY, VOLUME: 37, ISSUE: 10
INDEXED IN: WOS
67
TITLE: Safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks  Full Text
AUTHORS: Carlos Alves; Ana Filipa Macedo; Francisco Batel Marques;
PUBLISHED: 2014, SOURCE: Virtual Poster Symposium of the American-College-of-Clinical-Pharmacy in PHARMACOTHERAPY, VOLUME: 34, ISSUE: 6
INDEXED IN: WOS
68
TITLE: Safety monitoring of ophthalmic biologics: analysis of pre and post-marketing safety data  Full Text
AUTHORS: Ana Penedones; Francisco Batel Marques;
PUBLISHED: 2014, SOURCE: Virtual Poster Symposium of the American-College-of-Clinical-Pharmacy in PHARMACOTHERAPY, VOLUME: 34, ISSUE: 6
INDEXED IN: WOS
Page 7 of 9. Total results: 86.